PER2 and osteosarcoma: To test the feasibility of an in vitro CCD approach, we chose a commonly used circadian model [20], human U2 osteosarcoma (U2OS) cells expressing a Period2 (Per2) promoter-driven destabilized luciferase reporter (pPer2-dLuc).